文献速递银屑病与炎症性皮肤病自身免疫性与大疱性皮肤病

靶向白介素-1家族细胞因子在慢性炎症性皮肤病中的治疗潜力

Therapeutic potential of targeting interleukin-1 family cytokines in chronic inflammatory skin diseases.
PubMed 文献 · Br J Dermatol · 2022-03-22

本文综述白介素(IL)-1家族细胞因子(包括IL-1、IL-36、IL-18亚家族及IL-33)在慢性炎症性皮肤病中的作用,并讨论靶向这些细胞因子及其信号通路的治疗策略,指出多种抑制剂已在若干慢性炎症性皮肤病中显示治疗疗效。

要点

  • IL-1家族细胞因子是免疫反应的核心调节因子,参与固有免疫和适应性免疫。
  • IL-1信号失调是多种单基因自身炎症性疾病的发病基础,累及皮肤等器官。
  • 靶向IL-1家族成员及其信号通路的药物在多种慢性炎症性皮肤病中显示治疗疗效。

核心结论

  • 靶向IL-1、IL-33、IL-36和IL-18通路是慢性炎症性皮肤病的潜在治疗策略。

研究设计与样本

  • 综述,检索范围未在原文中报告。

主要发现

  • IL-1家族包括IL-1、IL-36和IL-18亚家族成员以及IL-33。
  • IL-1信号失调参与单基因自身炎症性疾病、中性粒细胞性皮肤病、银屑病和化脓性汗腺炎的发病。
  • 多种抑制IL-1家族成员及其信号通路的治疗药物已在若干慢性炎症性皮肤病中显示治疗疗效。

关键数值与推荐

  • 原文未报告具体标准与数值。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The interleukin (IL)-1 family of cytokines is a central regulator of a myriad of immunological responses. It comprises several cytokines, including those belonging to the IL-1, IL-36 and IL-18 subfamilies, as well as IL-33. The IL-1 family primarily plays a role in orchestrating innate immune responses, but is also involved in adaptive immunity. Increased interest in the IL-1 family occurred following the discovery that dysregulation of IL-1 signalling underlies the pathogenesis of several monogenic autoinflammatory diseases, characterized by sterile inflammation involving the skin and other organs. This also provided increased understanding of the role of innate immunity and the IL-1 family in polygenic autoinflammatory skin conditions, such as neutrophilic dermatoses, as well as in some of the most common chronic inflammatory skin diseases, such as psoriasis and hidradenitis suppurativa. Several therapeutic agents have been developed to inhibit the IL-1 family members and their signalling pathways. These have shown therapeutic efficacy in several chronic inflammatory skin disorders. The aim of this review is to thoroughly describe the consequences of pathological dysregulation of the IL-1, IL-33, IL-36 and IL-18 pathways in dermatological conditions and to provide a forward-looking update on therapeutic strategies targeting signalling by IL-1 family cytokines.

来源:Br J Dermatol,查看原文。版权归原作者所有。

引用

  1. Calabrese L, Fiocco Z, Satoh TK, et al. Therapeutic potential of targeting interleukin-1 family cytokines in chronic inflammatory skin diseases. Br J Dermatol. 2022. PMID: 34990008. doi:10.1111/bjd.20975

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。